Biosafety Level 2 Model of Pneumonic Plague and Protection Studies with F1 and Psa

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Infection and Immunity

• Publication date

  2010-05-24

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1128/IAI.00382-10PMID 20498260PMCID PMC2916268
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Yersinia pestis with Regulated Delayed Attenuation as a Vaccine Candidate To Induce Protective Immunity against Plague

  2010cited by this paper
• Deletion of Braun lipoprotein gene (lpp) attenuates Yersinia pestis KIM/D27 strain: role of Lpp in modulating host immune response, NF-kappaB activation and cell death.

  2010cited by this paper
• A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.

  2010cited by this paper
• The smpB-ssrA Mutant of Yersinia pestis Functions as a Live Attenuated Vaccine To Protect Mice against Pulmonary Plague Infection

  2010cited by this paper
• The Yersiniabactin Transport System Is Critical for the Pathogenesis of Bubonic and Pneumonic Plague

  2010influential reference
• Iron availability and infection.

  2009cited by this paper
• The subcutaneous inoculation of pH 6 antigen mutants of Yersinia pestis does not affect virulence and immune response in mice.

  2009cited by this paper
• Absence of Inflammation and Pneumonia during Infection with Nonpigmented Yersinia pestis Reveals a New Role for the pgm Locus in Pathogenesis

  2009cited by this paper
• The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague

  2009cited by this paper
• Plague vaccines and the molecular basis of immunity against Yersinia pestis

  2009cited by this paper
• Novel Broad-Spectrum Bis-(Imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains

  2009cited by this paper
• Plague into the 21st century.

  2009cited by this paper
• Capsular Antigen Fraction 1 and Pla Modulate the Susceptibility of Yersinia pestis to Pulmonary Antimicrobial Peptides Such as Cathelicidin

  2008cited by this paper
• Current challenges in the development of vaccines for pneumonic plague

  2008influential reference
• Targeting Type III Secretion in Yersinia pestis

  2008cited by this paper
• Isolation and Confirmation of Yersinia pestis Mutants Exempt from Select Agent Regulations

  2008cited by this paper
• Immune defense against pneumonic plague

  2008cited by this paper
• Antibody profiling in plague patients by protein microarray.

  2008cited by this paper
• Laboratory Maintenance and Characterization of Yersinia pestis

  2008cited by this paper
• Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92.

  2008cited by this paper
• Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice

  2008cited by this paper
• Risk Communication Planning for the Aftermath of a Plague Bioattack

  2008cited by this paper
• Effector functions of pathogenic Yersinia species

  2007cited by this paper
• Yersinia pestis YadC: a novel vaccine candidate against plague.

  2007cited by this paper
• Transcriptome analysis of Yersinia pestis in human plasma: an approach for discovering bacterial genes involved in septicaemic plague.

  2007cited by this paper
• Multiple Antimicrobial Resistance in Plague: An Emerging Public Health Risk

  2007cited by this paper
• FGL chaperone-assembled fimbrial polyadhesins: anti-immune armament of Gram-negative bacterial pathogens.

  2007cited by this paper
• Effect of iron and phagocytosis on murine macrophage activation in vitro

  2007cited by this paper
• Acellular pertussis vaccines and the role of pertactin and fimbriae

  2007cited by this paper
• Effects of Psa and F1 on the Adhesive and Invasive Interactions of Yersinia pestis with Human Respiratory Tract Epithelial Cells

  2006cited by this paper
• The Psa Fimbriae of Yersinia pestis Interact with Phosphatidylcholine on Alveolar Epithelial Cells and Pulmonary Surfactant

  2006cited by this paper
• Administration of Antibody to the Lung Protects Mice against Pneumonic Plague

  2006cited by this paper
• Gamma Interferon, Tumor Necrosis Factor Alpha, and Nitric Oxide Synthase 2, Key Elements of Cellular Immunity, Perform Critical Protective Functions during Humoral Defense against Lethal Pulmonary Yersinia pestis Infection

  2006cited by this paper
• RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague

  2006cited by this paper
• Flagellin Is an Effective Adjuvant for Immunization against Lethal Respiratory Challenge with Yersinia pestis

  2006cited by this paper
• Delayed Inflammatory Response to Primary Pneumonic Plague Occurs in Both Outbred and Inbred Mice

  2006cited by this paper
• Human Immune Response to a Plague Vaccine Comprising Recombinant F1 and V Antigens

  2005cited by this paper
• Anti-LcrV Antibody Inhibits Delivery of Yops by Yersinia pestis KIM5 by Directly Promoting Phagocytosis

  2005cited by this paper
• Immunization of mice with YscF provides protection from Yersinia pestis infections

  2005cited by this paper
• Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.

  2005cited by this paper
• Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity.

  2005cited by this paper
• Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus.

  2005cited by this paper
• Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum.

  2005cited by this paper
• Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.

  2005cited by this paper
• Acellular Pertussis Vaccines for Adolescents

  2005cited by this paper
• Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.

  2005cited by this paper
• Hemochromatosis and the enigma of misplaced iron: Implications for infectious disease and survival

  2004cited by this paper
• Yersinia: molecular and cellular biology.

  2004cited by this paper
• The pH 6 Antigen Is an Antiphagocytic Factor Produced by Yersinia pestis Independent of Yersinia Outer Proteins and Capsule Antigen

  2004cited by this paper
• Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.

  2004cited by this paper
• Biological weapons defense: infectious disease and counterbioterrorism.

  2004cited by this paper
• Structure, chemistry, and pharmacokinetics of intravenous iron agents.

  2004influential reference
• Comparison of injectable iron complexes in their ability to iron load tissues and to induce oxidative stress

  2003cited by this paper
• Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.

  2003cited by this paper
• Development and Evaluation of an Improved Mouse Model of Meningococcal Colonization

  2003cited by this paper
• Crucial role of antibodies to pertactin in Bordetella pertussis immunity.

  2003cited by this paper
• Immunohistochemical detection of Yersinia pestis in formalin-fixed, paraffin-embedded tissue.

  2002cited by this paper
• Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals

  2002cited by this paper
• Vaccination against bubonic and pneumonic plague.

  2001cited by this paper
• Microbial pathogens with impaired ability to acquire host iron

  2000cited by this paper
• Pathogenesis of Infection by Clinical and Environmental Strains of Vibrio vulnificus in Iron-Dextran-Treated Mice

  2000cited by this paper
• Protective Efficacy of RecombinantYersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis

  1999cited by this paper
• Yersinia pestis--etiologic agent of plague

  1997cited by this paper
• Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge

  1996cited by this paper
• Determination of median lethal and infectious doses in animal model systems.

  1994cited by this paper
• Permissive linker insertion sites in the outer membrane protein of 987P fimbriae of Escherichia coli

  1994cited by this paper
• Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague

  1990cited by this paper
• Genetic analysis of the low calcium response in Yersinia pestis mu d1(Ap lac) insertion mutants

  1984cited by this paper
• Neisseria meningitidis infection in mice: influence of iron, variations in virulence among strains, and pathology

  1979cited by this paper
• A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

  1978cited by this paper
• Plague immunization. I. Past and present trends.

  1974cited by this paper
• The effect of an iron drug on host response to experimental plague infection.

  1972cited by this paper
• Histopathological changes of mice injected with plague live vaccine strain EV.

  1970cited by this paper
• The virulence-enhancing effect of iron on nonpigmented mutants of virulent strains of Pasteurella pestis.

  1956cited by this paper
• QUANTITATIVE ASPECTS OF IRON DEFICIENCY IN HYPOCHROMIC ANEMIA: (The Parenteral Administration of Iron).

  1932cited by this paper

• A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague

  2024influential citation
• Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories

  2021cites this paper
• Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.

  2021cites this paper
• Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague

  2020cites this paper
• Yersinia Outer Membrane Vesicles as Potential Vaccine Candidates in Protecting against Plague

  2020cites this paper
• Shift from primary pneumonic to secondary septicemic plague by decreasing the volume of intranasal challenge with Yersinia pestis in the murine model

  2019cites this paper
• Chapter 12 Plague vaccines: status and future

  2019cites this paper
• Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system

  2019cites this paper
• Cooperation of Adhesin Alleles in Salmonella-Host Tropism

  2017cites this paper
• Structural basis for Myf and Psa fimbriae‐mediated tropism of pathogenic strains of Yersinia for host tissues

  2016influential citation
• Plague Vaccines: Status and Future.

  2016cites this paper
• Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System

  2016cites this paper
• Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague.

  2014cites this paper
• Nucleic acid modifications in bacterial pathogens - impact on pathogenesis, diagnosis, and therapy

  2014cites this paper
• Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.

  2013cites this paper
• Fimbrial polyadhesins: anti-immune armament of Yersinia.

  2012cites this paper
• Structural basis for the specific recognition of dual receptors by the homopolymeric pH 6 antigen (Psa) fimbriae of Yersinia pestis

  2012cites this paper
• Hereditary hemochromatosis restores the virulence of plague vaccine strains.

  2012cites this paper
• Advances in Yersinia Research

  2012cites this paper
• The outer membrane protein A (OmpA) of Yersinia pestis promotes intracellular survival and virulence in mice.

  2012cites this paper
• The Outer Membrane Protein A (OmpA) of Y. pestis promotes intracellular survival and virulence in mice

  2011cites this paper
• Progress on plague vaccine development

  2011cites this paper
• The Dependence of the Yersinia pestis Capsule on Pathogenesis Is Influenced by the Mouse Background

  2010cites this paper
• Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA.

  2010cites this paper